Javelin Oncology

Javelin Oncology develops targeted immunotherapies by precisely matching patients to the most effective treatments. The company leverages advanced diagnostics to identify unique immune signatures, enabling the design of personalized cancer therapies with improved efficacy.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

Javelin Oncology develops targeted immunotherapies by precisely matching patients to the most effective treatments. The company leverages advanced diagnostics to identify unique immune signatures, enabling the design of personalized cancer therapies with improved efficacy.